###begin article-title 0
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 158 202 158 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G protein-coupled receptor 143 gene (GPR143)</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
There are few genetic studies and clinical descriptions of Asian patients with X-linked ocular albinism (OA1). In the present study, the mutation analysis of G protein-coupled receptor 143 gene (GPR143) and clinical characteristics were assessed in Chinese patients with OA1.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
Six families with OA1 were recruited from our pediatric and genetic eye clinic. Genomic DNA was prepared from venous leukocytes. The coding regions of GPR143 were amplified by polymerase chain reaction, and subsequently analyzed by direct sequencing. The variations detected were further evaluated in available family members as well as controls.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 558 566 <span type="species:ncbi:9606">patients</span>
Mutations in GPR143 were identified in each of the six families: c.849delT (p.Val284SerfsX15); c.238_240delCTC (p.Leu80del); c.658+1G>A, c.353G>A (p.Gly118Glu); g.1103_7266del6164 (p.Gly84AlafsX65), which resulted in a deletion of exons 2 and 3; and g.25985_26546del562 (p.Gly296ValfsX26), which resulted in a deletion of exon 8. Of these six, c.353G>A is a known mutation, while the other five are novel. All affected patients had nystagmus, poor visual acuity, and foveal hypoplasia. However, hypopigmentation of the iris and fundus was very mild in these patients.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
Five novel mutations and one known mutation were identified in six Chinese families with OA1. These results expand the mutation spectrum of GPR143, and demonstrate the clinical characteristics of OA1 among the Chinese.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 453 459 <span type="species:ncbi:9606">people</span>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
X-linked ocular albinism (OA1; OMIM ), also called ocular albinism type 1, is the most common form of ocular albinism. Most affected white males exhibit nystagmus, poor visual acuity, iris translucency, foveal hypoplasia, an albinotic fundus, and normally pigmented skin and hair [1-4]. Other findings may include photophobia, strabismus, and misrouting of the optic tracts, resulting in loss of stereoscopic vision [5-7]. In some OA1 patients of black people, O'Donnell found hypopigmentation of the iris and retina may be subtle, such that these patients present a nonalbinotic fundus and little iris translucency [8]. However, the characteristics of OA1 have not been well defined in Asians. The misdiagnosis of OA1 as congenital nystagmus is not uncommon, and is usually due to lack of clinical experience or lack of phenotypic characterization for certain ethnic groups [9-14]. Such misdiagnoses might have gone undetected before the OA1 gene was identified.
###end p 11
###begin p 12
###xml 34 73 34 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G protein-coupled receptor 143 (GPR143)</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
OA1 is caused by mutations in the G protein-coupled receptor 143 (GPR143) gene (OMIM ), originally also known as the OA1 gene, located at Xp22.32 [15-17]. Various types of mutations in GPR143 have been identified in Caucasians living in the Netherlands, the United Kingdom, the United States, Germany, Canada, Belgium, France, Italy, and South Africa (). Interestingly, genetic studies of Chinese patients with OA1 are rare.
###end p 12
###begin p 13
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
In this study, sequence analysis of GPR143 resulted in the identification of mutations in each family, including five novel and one known mutations. Furthermore, we describe the clinical characteristics of OA1 patients and female carriers from six Chinese families.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 65 73 65 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 184 190 <span type="species:ncbi:9606">people</span>
###xml 369 380 <span type="species:ncbi:9606">participant</span>
###xml 772 779 <span type="species:ncbi:9606">patient</span>
There are 15 patients and 7 carriers participated in this study (Figure 1, Table 1), further more, 100 normal male controls mainly from the South of China also take part in, all these people are collected by our Pediatric and Genetic Clinic of Zhongshan Ophthalmic Center. Informed consent conforming to the tenets of the Declaration of Helsinki was obtained from each participant before the study. Medical and ophthalmic histories were obtained. Ophthalmological examination including visual acuity assessment , slit lamp biomicroscopic and ophthalmoscopic observation was performed by Drs. Guo and Zhang. Anterior and posterior segments of the eyes were documented by slit lamp and fundus photography. Flash visual evoked potential (VEP) was performed in one 4-year-old patient (proband in family 3). Genomic DNA was prepared from leukocytes of peripheral venous blood using the phenol-chloroform extracted method.
###end p 16
###begin p 17
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Pedigrees of the six families are shown. Black filled symbols indicate patients affected with OA1 in each family. Dot-marked symbols represent carriers. The proband is marked by arrow in each family.
###end p 17
###begin title 18
Summary of clinical findings in affected males and carriers
###end title 18
###begin p 19
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Clinical characteristics including gender, age, first symptom, visual acuity, iris, and fundus hypopigmentation form 15 OA1 patients and 7 carriers were conclude in this table. Abbreviations: albinotic fundus (a); hypopigmentation (b); foveal hypoplasia (c); not determined (ND); not applicable (NA), visual acuity(VA); nystagmus (Nys).
###end p 19
###begin title 20
Mutation analysis
###end title 20
###begin p 21
###xml 25 32 25 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Eleven pairs of primers (Table 2) were used to amplify the nine coding exons and the adjacent intronic sequences of GPR143 (NCBI human genome build 36.2, GeneID 4935,  for gDNA,  for mRNA,  for protein). Sequence analysis was performed as previously described [18]. The numbering system of the nucleotides for 404 amino acids, but not 424, was used for mutation description as previously described [19] (see in "In silico analysis" part).
###end p 21
###begin title 22
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
Primers for amplifying and sequencing GPR143 genomic segments.
###end title 22
###begin p 23
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SSCP-1</italic>
Listed are primer sequences, sizes of PCR products, and annealing temperature used for the amplification. Primers 1-9 were used to amplify and sequence the GPR143 genimic segments. Primers FAM5 and FAM6 were used to detect the deletion boundaries in families 5 and 6, respectively. Primers SSCP-1 to 3 were used to amplify exons 1, 5, and 7 for heterduplex-SSCP analysis.
###end p 23
###begin p 24
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Any variations detected, except for two large intragenic deletions, were further evaluated in available family members as well as in 100 Chinese normal male controls using heteroduplex-single strand conformation polymorphism (SSCP) analysis, as previously described [20]. Three additional pairs of primers (Table 2, available on request) [21] were synthesized for heteroduplex-SSCP analysis of exons 1, 5, and 7.
###end p 24
###begin p 25
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
In family 5, no PCR products were produced for the DNA fragments encompassing exons 2 and 3 of GPR143, suggesting a deletion in this region. To define the boundaries of the deletion, we designed a series of primer pairs based on sequences between exons 1 and 4 to amplify junctional fragments harboring the deletion. The deletion boundary was finally identified using the primer pairs shown in Table 2 (FAM5). In family 6, no PCR product was detected for exon 8. We used the same technique to find the deletion boundary with the primer pairs FAM6 shown in Table 2.
###end p 25
###begin title 26
In silico analysis
###end title 26
###begin p 27
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 270 275 <span type="species:ncbi:9606">human</span>
###xml 536 541 <span type="species:ncbi:9606">Human</span>
Direct sequencing of the PCR products was performed with an ABI BigDye Terminator Cycle Sequencing Kit v3.1 (ABI Applied Biosystems, Foster City, CA) using an ABI3100 Genetic Analyzer. Sequencing results from patients as well as GPR143 consensus sequences from the NCBI human genome database () were imported into the SeqManII program of the Lasergene package (DNAStar Inc., Madison, WI) to identify variations. Each mutation was confirmed by bidirectional sequencing. Mutation descriptions followed the nomenclature recommended by the Human Genomic Variation Society (). To evaluate the splice site mutation, we used the Automated Splice Site Analysis () server [22] to analyze the possible effects of this kind of mutation.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Clinical phenotype
###end title 29
###begin p 30
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 104 112 104 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 230 238 230 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 243 251 243 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
The clinical characteristics of OA1 in Chinese individuals are described as in Table 1 and Figure 2 and Figure 3. Table 1 shows the gender, age and clinical characteristics of the 15 patients and 7 carriers from the six families. Figure 2 and Figure 3 show some of the patients and carriers' iris and fundus image respectively.
###end p 30
###begin p 31
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 349 350 349 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 352 353 352 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 455 456 455 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 117 123 <span type="species:ncbi:9606">person</span>
###xml 238 245 <span type="species:ncbi:9606">patient</span>
Photographs of irises from normal control, patients, and carriers. Both of eyes' irises are presented. A is a normal person whose irises exhibited normal pigmentation. B shows the irises of proband (III:3) in family 2. He is the only one patient who had obvious iris hypopigmentation. Obvious hypopigmentation is observed in both of eyes in picture B. C is the proband (IV:1) of family 4, showing slightly hypopigmentation in peripheral of the both eyes. D is carrier (III:3) in family 4. Her iris hypopigmentation is also very mild in both of eyes.
###end p 31
###begin p 32
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 139 140 139 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 274 275 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 277 278 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 443 444 443 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 446 447 446 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Photographs of fundi from normal control, patients, and carriers. Both of eyes' fundi are presented. A is the fundi from a normal control. B shows the fundi of proband (IV:16) in family 1. There is normal pigmentation and severe foveal hypoplasia in both of eyes in picture B. C presents the fundi of proband IV:1 from family 4. There was hypopigmentation in the posterior of the fundus and severe foveal hypoplasia in both of eyes in picture C. D shows the fundi from carrier III:3 in family 4. There was pigmentary mosaicism in the retinal pigment epithelium, and the fovea was normal in both of eyes.
###end p 32
###begin title 33
Reduced visual acuity and nystagmus
###end title 33
###begin p 34
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 498 510 <span type="species:ncbi:9606">participants</span>
All OA1 patients who came to our ophthalmic center had nystagmus and poor visual acuity as a first symptom. The nystagmus was present since birth, and corrected visual acuity (VA) was between 0.1-0.3. No VA data were obtained for families 3 and 6 because the patients were not old enough (Table 1) to cooperate with the examination. Flash VEP was performed for the family 3 proband, and no abnormalities were observed. The carriers did not show any symptoms, and their VA was normal (Table 1). All participants studied had normal skin and hair.
###end p 34
###begin title 35
Iris hypopigmentation
###end title 35
###begin p 36
###xml 79 88 79 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 143 152 143 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 394 403 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2D</xref>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
This study examined 15 Chinese OA1 patients. Compared with normal individuals (Figure 2A), only one patient had obvious iris hypopigmentation (Figure 2B). Six patients exhibited mild peripheral iris hypopigmentation, as shown in Figure 2C, and eight patients had no abnormalities. Of the OA1 carriers, two exhibited mild peripheral iris hypopigmentation that could easily have been overlooked (Figure 2D), while the other carriers exhibited iris pigmentation that was similar to that in normal individuals.
###end p 36
###begin title 37
Hypopigmentation in the fundus and foveal hypoplasia
###end title 37
###begin p 38
###xml 81 90 81 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 132 141 132 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 220 229 220 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 329 338 329 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
###xml 463 472 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 567 576 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3C</xref>
###xml 801 810 801 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3D</xref>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 36 44 <span type="species:ncbi:9606">patients</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
This study examined the fundi of 13 patients'. Compared with normal individuals (Figure 3A), eight patients had normal pigmentation Figure 3B, three had mild hypopigmentation, and only two exhibited an albinotic fundus (Figure 3C). However, all of the patients had severe foveal hypoplasia (Table 1). In the proband of family 1 (Figure 3B), there was no typical albinotic fundus, and the fundus pigmentation had no abnormalities compared with normal individuals (Figure 3A). The only sign of the disease we observed was foveal hypoplasia. In the proband of family 4 (Figure 3C), hypopigmentation was apparent in the posterior of the fundus, and foveal hypoplasia was evident. Of the OA1 carriers, some had pigmentary mosaicism in the retinal pigment epithelium-for example, carrier III:3 in family 4 (Figure 3D)-while others had no hypopigmentation (Table 1).
###end p 38
###begin title 39
Mutation analysis
###end title 39
###begin p 40
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 84 92 84 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 98 107 98 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure, 4</xref>
###xml 763 769 763 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 783 791 783 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
Sequence analysis of GPR143 detected six mutations among the six families (Table 3, Figure 1, and Figure, 4). Each of the six families studied had one of the following mutations: c.849delT (p.Val284SerfsX15); c.238_240delCTC (p.Leu80del); c.658+1G>A; c.353G>A (p.Gly118Glu); g.1103_7266del6164 (p.Gly84AlafsX65), which resulted in a deletion of exons 2 and 3; and g.25985_26546del562 (p.Gly296ValfsX26), which resulted in a deletion of exon 8. Of these six, c.353G>A is a known mutation, and the other five are novel. These mutations were present in affected hemizygous males and obligate heterozygous female carriers in the families, but were not detected in unaffected males and 100 controls by heteroduplex-SSCP analysis. The locations of the six mutations in GPR143 are shown in Figure 4.
###end p 40
###begin title 41
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
GPR143 mutations identified in six Chinese families with OA1
###end title 41
###begin p 42
###xml 144 149 <span type="species:ncbi:9606">Human</span>
Five novel and one known mutations were identified in six Chinese families. The mutation was named according to the nomenclature recommended by Human Genomic Variation Society (). In the third column, i5 stands for intron 5. The asterisk indicates that the mutation has been previously reported.
###end p 42
###begin p 43
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 245 250 <span type="species:ncbi:9606">Human</span>
Sequencing analysis of six families with OA1. The mutant GPR143 sequence (left) and corresponding normal sequence (right) are shown for families 1-4. The exact mutation is labeled under each sequence according to the nomenclature recommended by Human Genomic Variation Society (). Each mutation is marked with an arrow. In family 5, direct sequencing image was obtained by direct sequencing. The long band in Family 5 including exons 2 and 3, represents the large intragenic deletion region, which encompasses about 6,164 bp from g.1103 to g.7266 of GPR143. In family 6, direct sequencing image was obtained by direct sequencing, and the lower long band represents the deletion from g.25985 to g.26546 encompassing exon 8. The location of the six mutations within GPR143 is exhibited at the bottom of the Figure 4. Exons are shown as open boxes numbered 1-9, and thin lines represent introns. The locations of the six mutations found in this study are indicated beside the exons.
###end p 43
###begin p 44
###xml 24 32 24 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 34 41 34 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 558 566 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 568 575 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
The c.849delT mutation (Figure 4, Table 3) is thought to induce a frameshift, creating a termination at codon 892. The resulting gene product lacks about a fourth of its amino acids, including the last transmembrane domain of the C-terminus. The c.238_240delCTC mutation resulted in a leucine deletion in the 80th amino acid position, and the c.353G>A mutation resulted in a replacement of glutamic acid with glycine in the 118th amino acid positions. The splice site mutation, c.658+1G>A, was expected to result in a loss of the corresponding splice sites (Figure 4, Table 3). The ASSA server [22] result predicted that the c.658+1G>A mutation would significantly change the strength of the splicing acceptor (from 9.2 bits to -3.6 bits) and would therefore abolish the natural splice site, corresponding to an approximately 594.6 fold decrease in the predicted affinity for this site. Two large intragenic deletions, g.1103_7266del6164 and g.25985_26546del562, resulted in the loss of an entire exon and produced what we believe to be a nonfunctional protein.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
In our study, we found five novel mutations and one known mutation in GPR143 among six unrelated Chinese families with OA1. All of the patients exhibited congenital nystagmus, poor visual acuity, mild hypopigmentation of the iris and fundus, and severe foveal hypoplasia.
###end p 46
###begin p 47
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 512 518 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 291 298 <span type="species:ncbi:9606">patient</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
Previous studies indicate that there is a higher detection of mutations in GPR143 in OA1 patients. Schiaffino et al. [2] screened the entire GPR143 coding sequence and detected mutations in one-third of patients. Schnur et al. [3] reported a higher frequency (90%) of mutations in their OA1 patient group. Here, our result indicate that Chinese OA1 patients also have a high frequency of mutations in GPR143 and further confirm that GPR143 is the major locus for OA1. Based on the high detection of mutations in GPR143, molecular genetic testing and prenatal diagnosis should be made available to Chinese OA1 patients.
###end p 47
###begin p 48
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 827 828 827 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 1116 1122 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 1335 1341 1335 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
###xml 641 649 <span type="species:ncbi:9606">patients</span>
###xml 834 842 <span type="species:ncbi:9606">patients</span>
###xml 1064 1072 <span type="species:ncbi:9606">patients</span>
###xml 1283 1291 <span type="species:ncbi:9606">patients</span>
Of the six mutations in our OA1 patients, there were four deletion mutations, one missense mutation, and one splice site mutation. These mutations mainly cluster within exons 1, 2, 3, and 7 of GPR143 (Figure 4), and the locations of the mutations are similar to previous studies. Large intragenic deletion is a common mutation in GPR143. Bassi et al. [23] found a diverse prevalence of large deletions between European (<10%) and North American (>50%) patients with OA1. Interestingly we also found two large intragenic deletions in our OA1 patients. These results may indicate that large intragenic deletions are also common in Chinese OA1 patients. The c.353G>A (p.Gly118Glu) mutation, resulting in the replacement of glutamic acid with glycine at the 118th amino acid position, has been identified in Caucasian populations [3] and patients from the Netherlands [23]. And this is the third time to report it, the mutation appeared in different ethnic groups indicate that c.353G>A (p.Gly118Glu) may be a hot spot mutation. Our result also shows that Chinese OA1 patients may have a similar spectrum of mutation in GPR143 compared with the White group. This mutation may therefore be a hot spot mutation in different ethnic groups. The findings from our study show that Chinese OA1 patients may have a similar spectrum of mutation in GPR143 compared with the Caucasian group.
###end p 48
###begin p 49
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
The OA1 patients in our study exhibited congenital nystagmus and poor visual acuity with mild hypopigmentation of the iris and fundus. Liu et al. [12] reported a large X-linked recessive inheritance in a Chinese family with nystagmus as a prominent and consistent manifestation of the phenotype. None of the patients in the family had the complete classical phenotype of ocular albinism, and patients were initially misdiagnosed with congenital nystagmus. The disease gene was mapped to a region approximately 10.6 Mb in size, flanked by DXS996 and DXS7593 on Xp22 with a significant peak multipoint LOD score. Analysis of 21 candidate genes in the region revealed a novel p.S89F mutation in the second transmembrane domain of GPR143.
###end p 49
###begin p 50
###xml 1254 1260 1254 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 97 104 <span type="species:ncbi:9606">patient</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 986 994 <span type="species:ncbi:9606">patients</span>
###xml 1066 1074 <span type="species:ncbi:9606">patients</span>
In our OA1 patients, iris hypopigmentation ranged from mild to normal, with the exception of one patient. It was difficult to distinguish any differences compared to normal individuals. Our OA1 patients showed little change in clinical characteristics of the fundus, exhibiting only mild hypopigmentation and sometimes even normal pigmentation. Severe foveal hypoplasia was the prominent clinical feature observed in Chinese OA1 patients, which may be a useful criterion for distinguishing OA1 from nystagmus of unknown cause. As hypopigmentation of the iris and fundus is not typical among the Chinese, OA1 could easily be misdiagnosed as another disease due to the presence of nystagmus and severely reduced visual acuity. Although foveal hypoplasia may be a key indicator of OA1, unawareness of the clinical characteristics of OA1 and lack of experience might explain why OA1 is rarely reported in the Chinese population. Here, we describe the characteristic signs of OA1 in Chinese patients, potentially facilitating the diagnosis of OA1 in this population. For patients presenting with nystagmus and reduced visual acuity, careful evaluation of iris color, fundus color, and foveal development is critical. Furthermore, molecular genetic testing of GPR143 might be useful for establishing a diagnosis of OA1.
###end p 50
###begin p 51
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GPR143</italic>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
In summary, this report identified five novel mutations and one known mutation in GPR143 of Chinese OA1 patients. Moreover, we examined the clinical features of Chinese OA1 patients and found that foveal hypoplasia may be a key indicator of OA1 in patients with nystagmus of unknown cause. Identification of mutations in GPR143 and more information regarding clinical manifestations should facilitate early diagnosis, appropriate early therapy, and genetic counseling for this disease.
###end p 51
###begin title 52
ACKNOWLEDGMENTS
###end title 52
###begin p 53
###xml 13 21 <span type="species:ncbi:9606">patients</span>
We thank the patients and family members for their participation. This study was supported in part by the National 863 Plan of China (04AA104092; to X.G.), the National Natural Science Foundation of China (30572006; to Q.Z.), the National Science Fund for Distinguished Young Scholars of China (30725044; to Q.Z.), and the Guangdong Natural Science Foundation (04009335; to X.G.).
###end p 53
###begin title 54
References
###end title 54
###begin article-title 55
###xml 27 32 <span type="species:ncbi:9606">human</span>
Visual system anomalies in human ocular albinos.
###end article-title 55
###begin article-title 56
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism.
###end article-title 56
###begin article-title 57
OA1 mutations and deletions in X-linked ocular albinism.
###end article-title 57
###begin article-title 58
The ocular albinism type 1 gene product is an N-glycoprotein but glycosylation is not required for its subcellular distribution.
###end article-title 58
###begin article-title 59
X-linked ocular albinism.
###end article-title 59
###begin article-title 60
Ocular albinism
###end article-title 60
###begin article-title 61
Electronystagmographic investigation in X-linked ocular albinism.
###end article-title 61
###begin article-title 62
X-linked ocular albinism in Blacks. Ocular albinism cum pigmento.
###end article-title 62
###begin article-title 63
Deletion in the OA1 gene in a family with congenital X linked nystagmus.
###end article-title 63
###begin article-title 64
Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay.
###end article-title 64
###begin article-title 65
Scanning the ocular albinism 1 (OA1) gene for polymorphisms in congenital nystagmus by DHPLC.
###end article-title 65
###begin article-title 66
Identification of a novel GPR143 mutation in a large Chinese family with congenital nystagmus as the most prominent and consistent manifestation.
###end article-title 66
###begin article-title 67
Linkage analysis of two families with X-linked recessive congenital motor nystagmus.
###end article-title 67
###begin article-title 68
Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1).
###end article-title 68
###begin article-title 69
An Xp22 microdeletion associated with ocular albinism and ichthyosis: approximation of breakpoints and estimation of deletion size by using cloned DNA probes and flow cytometry.
###end article-title 69
###begin article-title 70
Linkage analysis in X-linked ocular albinism.
###end article-title 70
###begin article-title 71
X-linked ocular albinism and sensorineural deafness: linkage to Xp22.3.
###end article-title 71
###begin article-title 72
The 208delG mutation in FSCN2 does not associate with retinal degeneration in Chinese individuals.
###end article-title 72
###begin article-title 73
Delay in diagnosis of Williams syndrome.
###end article-title 73
###begin article-title 74
Exon-by-exon screening for RB germline mutations using Heteroduplex-SSCP analysis.
###end article-title 74
###begin article-title 75
Eight previously unidentified mutations found in the OA1 ocular albinism gene.
###end article-title 75
###begin article-title 76
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Novel mutations of the PAX6 gene identified in Chinese patients with aniridia.
###end article-title 76
###begin article-title 77
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America.
###end article-title 77

